Scientists find common ground in endocrine spat

Minutes of a recent meeting chaired by the EU executive show agreement over the difficulty of determining thresholds below which EDCs are safe

Scientists fighting over the correct approach to assessing the risks from endocrine disrupting chemicals (EDCs) seem to have found some common ground at a meeting chaired by the European Commission’s chief scientist last month.

But the commission’s work on EDCs is still behind schedule with a paper on their authorisation under REACH, expected this week, unlikely to emerge.

It is also unclear when criteria for defining EDCs under the EU’s pesticide and biocide rules, which are due in mid-December, will be finalised.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.